Dr. Dafer Al-Haddadin, MD
Claim this profileFranciscan Health Michigan City
Studies Coronavirus
Studies COVID-19
2 reported clinical trials
5 drugs studied
Area of expertise
1Coronavirus
SARS-CoV-2
PCR
collection
2COVID-19
SARS-CoV-2
Affiliated Hospitals
More about Dafer Al-Haddadin, MD
Clinical Trial Related1 year of experience running clinical trials · Led 2 trials as a Principal Investigator · 0 Active Clinical TrialsTreatments Dafer Al-Haddadin, MD has experience with
- Montelukast
- Placebo
- Fluticasone
- Fluvoxamine
- Ivermectin
Breakdown of trials Dafer Al-Haddadin, MD has run
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Dafer Al-Haddadin, MD specialize in?
Dafer Al-Haddadin, MD focuses on Coronavirus and COVID-19. In particular, much of their work with Coronavirus has involved SARS-CoV-2 patients, or patients who are PCR.
Is Dafer Al-Haddadin, MD currently recruiting for clinical trials?
No, Dafer Al-Haddadin, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Dafer Al-Haddadin, MD has studied deeply?
Yes, Dafer Al-Haddadin, MD has studied treatments such as Montelukast, Placebo, Fluticasone.
What is the best way to schedule an appointment with Dafer Al-Haddadin, MD?
Apply for one of the trials that Dafer Al-Haddadin, MD is conducting.
What is the office address of Dafer Al-Haddadin, MD?
The office of Dafer Al-Haddadin, MD is located at: Franciscan Health Michigan City, Michigan City, Indiana 46360 United States. This is the address for their practice at the Franciscan Health Michigan City.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.